CARISMA THERAPEUTICS TO PRESENT AT SOLEBURY CAPITAL SPRING PRIVATE COMPANY SHOWCASE

March 11, 2021

CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced that Steven Kelly, the President & CEO, will present at a virtual investor conference in March.

Solebury Trout Winter Private Company Showcase
March 11, 2021
Presentations can be found here.

About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.

For more information, please visit www.carismatx.com